A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.

Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metastatic, Locally Advanced or Non-Resectable)

NCT00374868 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Alimta and Gemcitabine in Non-Small Cell Lung Cancer

NCT00434135 ·Status: COMPLETED ·Phase: PHASE2

Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma

NCT00470405 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium

NCT00035061 ·Status: COMPLETED ·Phase: PHASE2

Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma

NCT00087698 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma

NCT00190801 ·Status: COMPLETED ·Phase: PHASE2

Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer

NCT00259285 ·Status: TERMINATED ·Phase: PHASE2

Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC

NCT01742767 ·Status: UNKNOWN ·Phase: PHASE2

Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer

NCT00055432 ·Status: TERMINATED ·Phase: PHASE2

Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy

NCT00630149 ·Status: COMPLETED ·Phase: PHASE2

Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

NCT00003427 ·Status: COMPLETED ·Phase: PHASE1

Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.

NCT00061464 ·Status: COMPLETED ·Phase: PHASE2

Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer

NCT00503997 ·Status: COMPLETED ·Phase: PHASE2

A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer

NCT00482014 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer

NCT00101842 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT00071136 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem

NCT00612677 ·Status: TERMINATED ·Phase: PHASE2

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial

NCT00061451 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

NCT00517595 ·Status: COMPLETED ·Phase: PHASE2

ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.

NCT00040625 ·Status: APPROVED_FOR_MARKETING

Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors

NCT00390000 ·Status: COMPLETED ·Phase: PHASE1

Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer

NCT00365183 ·Status: TERMINATED ·Phase: PHASE2

Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer

NCT00394147 ·Status: TERMINATED ·Phase: PHASE2

A Study for Patients With Head and Neck Cancer

NCT00415194 ·Status: COMPLETED ·Phase: PHASE3

Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer

NCT00276861 ·Status: TERMINATED ·Phase: PHASE2